Alterity Therapeutics Limited (ATHE:NASDAQ) shot up at $3.43, a gain of 154.1%. On Mon 03 Aug 20, ATHE:NASDAQ hit a New 2-Week Low of $1.35. The stock appeared on our News Catalysts scanner on Tue 04 Aug 20 at 06:11 AM in the 'MISCELLANEOUS' category. From Mon 20 Jul 20, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Wed 01 Jul 20 at $2.35 with a volume of 46M+, and its share price has been moving sideways in recent weeks.
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- Alterity Therapeutics Limited (ATHE:NASDAQ), 154.07%
- SilverSun Technologies, Inc. (SSNT:NASDAQ), 96.36%
- Sintx Technologies, Inc. (SINT:NASDAQ), 53.05%
- Whiting Petroleum Corporation (WLL:NYSE), 40.26%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 39.17%
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 38.18%
- iRhythm Technologies, Inc. (IRTC:NASDAQ), 32.63%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 31.42%
- Technical Communications Corporation (TCCO:NASDAQ), 29.89%
- Ossen Innovation Co., Ltd. (OSN:NASDAQ), 29.75%